The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer

BACKGROUND: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall survival is suboptimal due to the high metastatic potential of early-stage NSCLC and there is substantial clinical need for additional efficacious adjuvant treatment opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Melosky, Barbara, Cheema, Parneet, Juergens, Rosalyn A., Leighl, Natasha B., Liu, Geoffrey, Wheatley-Price, Paul, Sacher, Adrian, Snow, Stephanie, Tsao, Ming-Sound, McLeod, Deanna, Chu, Quincy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600554/
https://www.ncbi.nlm.nih.gov/pubmed/34804219
http://dx.doi.org/10.1177/17588359211056306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600554/
https://www.ncbi.nlm.nih.gov/pubmed/34804219
http://dx.doi.org/10.1177/17588359211056306

Ejemplares similares